Pages that link to "Q38714812"

The following pages link to Metal-based drugs that break the rules (Q38714812):

Displaying 38 items.

• Silver complexes of ligands derived from adamantylamines: Water-soluble silver-donating compounds with antibacterial properties (Q31150274) (← links)
• Application of imaging mass spectrometry approaches to facilitate metal-based anticancer drug research. (Q36268494) (← links)
• Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. (Q37724010) (← links)
• Metal complexes in cancer therapy - an update from drug design perspective (Q38692975) (← links)
• Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies (Q38770155) (← links)
• Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment (Q39220891) (← links)
• Synthesis and Assessment of Antibacterial Activities of Ruthenium(III) Mixed Ligand Complexes Containing 1,10-Phenanthroline and Guanide (Q41643582) (← links)
• Heteroleptic Copper(I) Complexes of "Scorpionate" Bis-pyrazolyl Carboxylate Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into Cytotoxic Mode. (Q42130456) (← links)
• Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand (Q46256422) (← links)
• Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity (Q46271057) (← links)
• High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium (Q46390552) (← links)
• A multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action. (Q46528613) (← links)
• Synthesis and functionalization of chitosan built hydrogel with induced hydrophilicity for extended release of sparingly soluble drugs (Q47212781) (← links)
• Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells. (Q47343997) (← links)
• Human topoisomerase inhibition and DNA/BSA binding of Ru(II)-SCAR complexes as potential anticancer candidates for oral application. (Q48113002) (← links)
• Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma (Q48252600) (← links)
• A general strategy to add diversity to ruthenium arene complexes with bioactive organic compounds via a coordinated (4-hydroxyphenyl)diphenylphosphine ligand (Q48259223) (← links)
• Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase Phosphorylation (Q48366295) (← links)
• Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines. (Q49860442) (← links)
• Quinoline-para-quinones and metals: coordination-assisted formation of quinoline-ortho-quinones (Q50098798) (← links)
• Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity. (Q51752552) (← links)
• Directed adenine functionalization for creating complex architectures for material and biological applications. (Q52685536) (← links)
• Enhanced Antimetastatic Activity of the Ruthenium Anticancer Drug RAPTA-C Delivered in Fructose-Coated Micelles. (Q52713012) (← links)
• Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective (Q56864516) (← links)
• Cellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts (Q58766014) (← links)
• Understanding the interactions of diruthenium anticancer agents with amino acids (Q60212382) (← links)
• A Selective and Cell-Permeable Mitochondrial Calcium Uniporter (MCU) Inhibitor Preserves Mitochondrial Bioenergetics after Hypoxia/Reoxygenation Injury (Q61451126) (← links)
• A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells. (Q64912759) (← links)
• Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands. (Q64957058) (← links)
• Structurally Characterized BODIPY-Appended Oxidovanadium(IV) β-Diketonates for Mitochondria-Targeted Photocytotoxicity (Q90153555) (← links)
• In vitro nephrotoxicity and anticancer potency of newly synthesized cadmium complexes (Q90663312) (← links)
• Anti-Trichomonas vaginalis activity of 1,10-phenanthroline-5,6-dione-based metallodrugs and synergistic effect with metronidazole (Q91399168) (← links)
• Binding mechanisms of half-sandwich Rh(III) and Ru(II) arene complexes on human serum albumin: a comparative study (Q91843271) (← links)
• Potent and selective in vitro and in vivo antiproliferative effects of metal-organic trefoil knots (Q92278082) (← links)
• Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity (Q92503045) (← links)
• Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines (Q92693906) (← links)
• Functionalization of Ruthenium(II)(η6 -p-cymene)(3-hydroxy-2-pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical Studies (Q92799889) (← links)
• Recent Considerations in the Application of RAPTA‐C for Cancer Treatment and Perspectives for Its Combination with Immunotherapies (Q110424723) (← links)